IPNO: Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers

Sponsor
Centro Cardiologico Monzino (Other)
Overall Status
Recruiting
CT.gov ID
NCT05775731
Collaborator
(none)
150
1
12.1
12.4

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn if acutely and/or chronically altered sleep induces inflammation and/or a pro-thrombotic state (a tendency to form clots) in hospital workers who either work in shifts or are exclusively daily workers. The main questions it aims to answer are:

  • Does chronically altered sleep induce a pro-inflammatory and pro-thrombotic state, which are steps towards cardiovascular disease, knowing that is associated with poor sleep?

  • Does acutely disrupted sleep, such as that observed in night shift workers, induce a pro-inflammatory and pro-thrombotic state in otherwise healthy subjects? Participants in the study are hospital workers who either work in shifts, including night shifts, or only during the day. Sleep quality is assessed by a validated questionnaire (the Pittsburgh Sleep Quality Index). Markers of inflammation and of the pro-thrombotic state are measured at baseline and, if appropriate, after the night shift. These are markers of platelet activation, D-dimer, Interleukin-6 and endothelin 1, known to contribute and/or to suggest a condition of generalized inflammation and a tendency to form clots. Relevant information on health status is also collected for each participant.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Tests for markers of inflammation and activated hemostasis

Detailed Description

Impaired sleep (quantity and quality) is associated with a number of chronic diseases, including an increased risk of cardiovascular events. Some forms of sleep impairment such as insomnia are very frequent and can be easily identified through dedicated and validated questionnaires. The pathway through which impaired sleep heightens cardiovascular risk is not known. Some limited studies suggest activation of coagulation could follow chronic sleep impairment. Atherosclerotic plaque formation is associated with the activation of coagulation, and with chronic inflammation. It would be interesting to know if chronic or acute sleep impairment, such as that experienced by night-shift hospital workers, could induce an inflammatory and pro-thrombotic state either acutely or chronically.

To test whether these hypotheses are correct, volunteer hospital workers who either work in shifts or do not will be enrolled, to test activation of inflammation and hemostasis through established markers (platelet, inflammation and coagulation activation markers). Shift workers will be analyzed before and after a night shift.

Data on anxiety and general health (chronic disorders, medications) as well as on sleep, through validated questionnaires, will be also collected.

Two groups: night-shift workers and daily workers will be compared. Comparisons will be carried out also within night-shift workers, at baseline and after a nigh shift. Finally, subjects who sleep well and who do not sleep well will be compared, independently of shift work.

The investigators believe that if it is shown that insomnia, a frequent and often not addressed sleep disturbance, is associated with a pro-inflammatory and pro-thrombotic state in otherwise healthy workers, this finding would have important consequences, first of all in designing prospective studies on the development of cardiovascular disease in altered sleep and its prevention.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Changes in Markers of Inflammation and of the Pro-thrombotic State Induced by Altered Sleep in Hospital Shift and Day Workers
Actual Study Start Date :
Sep 27, 2022
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
shift worker

- shift worker: works at least 60 nights per year Each subject will have blood taken twice (before and after the night-shift), and will answer three questionnaires [Pittsburgh Sleep Quality Index, Generalized Anxiety Disorder-7 (GAD-7) for anxiety disorder and a general health questionnaire]

Diagnostic Test: Tests for markers of inflammation and activated hemostasis
Volunteers who do not have exclusion criteria, are invited to complete the three questionnaires and to choose a date for blood drawing based on whether they are shift workers or not. Blood is immediately processed for platelet markers, and stored for inflammation and coagulation markers
Other Names:
  • Questionnaires
  • Pittsburgh Sleep Quality Index, General Anxiety Disorder-7
  • daily worker

    - daily worker: does not work at night (from 8 pm to 6 am) Each subject will have blood taken once, and will answer three questionnaires (Pittsburgh Sleep Quality Index, GAD-7 for anxiety disorder and a general health questionnaire)

    Diagnostic Test: Tests for markers of inflammation and activated hemostasis
    Volunteers who do not have exclusion criteria, are invited to complete the three questionnaires and to choose a date for blood drawing based on whether they are shift workers or not. Blood is immediately processed for platelet markers, and stored for inflammation and coagulation markers
    Other Names:
  • Questionnaires
  • Pittsburgh Sleep Quality Index, General Anxiety Disorder-7
  • Outcome Measures

    Primary Outcome Measures

    1. Sleep disorder [measurement relates to previous three months]

      Evaluation of altered sleep (chronic or acute) through PSQI questionnaire

    Secondary Outcome Measures

    1. Activation of inflammation and/or hemostasis [through study completion, an average of 8 months]

      altered markers of inflammation and hemostasis in shift workers. The markers considered are Endothelin 1, D-dimer, IL-6, complete platelet activation and microvesicle formation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Hospital worker who either works in shifts including night shifts, or only during the day
    Exclusion Criteria:
    • Known sleep disorder diagnosed by polysomnography and/or nocturnal saturation study

    • Sleep apnea-hypopnea syndrome in C-PAP (Continuous Positive Airway Pressure) treatment

    • Chronic treatment with sleep-inducers

    • Chronic heart failure class NYHA III and IV

    • Ischemic heart disease

    • Venous thromboembolism

    • Chronic anticoagulant and/or anti-platelet therapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centro Cardiologico Monzino Milan Italy 20138

    Sponsors and Collaborators

    • Centro Cardiologico Monzino

    Investigators

    • Principal Investigator: Elena M Faioni, MD, Centro Cardiologico Monzino

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centro Cardiologico Monzino
    ClinicalTrials.gov Identifier:
    NCT05775731
    Other Study ID Numbers:
    • CCM 1788
    First Posted:
    Mar 20, 2023
    Last Update Posted:
    Mar 20, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centro Cardiologico Monzino
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 20, 2023